\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ supportive\ \(54\)\
\-\ \\â\\€\\¢\\ extensive\\ bilateral\\ supratentorial\\ white\\ matter\\ lesions\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ mass\\ effect\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ contrast\\ enhancement\\.\ \(0\)\
\-\ amyloid\\ angiopathy\ \(2\)\
\-\ \\â\\€\\¢\\ herpes\\ encephalitis\ \(0\)\
\-\ \\â\\€\\¢\\ gliomatosis\\ cerebri\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ previously\\ healthy\\ 72\\ year\\ old\\ woman\\ who\\ presented\\ to\\ her\\ physician\\ with\\ a\\ 6\\ week\\ history\\ of\\ mental\\ deterioration\\ and\\ hallucinations\\.\ \(0\)\
\-\ biopsy\\ also\\ showed\\ neurofibrillary\\ tangles\\ and\\ plaques\\ consistent\\ with\\ alzheimers\\ diseaee\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1469075954621145\ \(0\)\
\-\ neurofibrillary\\:\\ 0\\.13774247537447654\ \(0\)\
\-\ tangles\\:\\ 0\\.13774247537447654\ \(0\)\
\-\ diseaee\\:\\ 0\\.13774247537447654\ \(0\)\
\-\ hallucinations\\:\\ 0\\.1269120506782274\ \(0\)\
\-\ alzheimers\\:\\ 0\\.1269120506782274\ \(0\)\
\-\ gliomatosis\\:\\ 0\\.10733762929548726\ \(0\)\
\-\ angiopathy\\:\\ 0\\.09347351687359816\ \(0\)\
\-\ deterioration\\:\\ 0\\.09173561632500091\ \(0\)\
\-\ cerebri\\:\\ 0\\.08808538427528988\ \(0\)\
\-\ supratentorial\\:\\ 0\\.0862450243431589\ \(0\)\
\-\ amyloid\\:\\ 0\\.0862450243431589\ \(0\)\
\-\ herpes\\:\\ 0\\.0862450243431589\ \(0\)\
\-\ 72\\:\\ 0\\.07570666422522464\ \(0\)\
\-\ encephalitis\\:\\ 0\\.07456979931456169\ \(0\)\
\-\ plaques\\:\\ 0\\.07456979931456169\ \(0\)\
\-\ physician\\:\\ 0\\.06293791689350707\ \(0\)\
\-\ mental\\:\\ 0\\.06230007322912808\ \(0\)\
\-\ healthy\\:\\ 0\\.06019802802666548\ \(0\)\
\-\ supportive\\:\\ 0\\.05904009096176358\ \(0\)\
\-\ previously\\:\\ 0\\.05609018359770777\ \(0\)\
\-\ extensive\\:\\ 0\\.05339618316326165\ \(0\)\
\-\ matter\\:\\ 0\\.052569999537512464\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.04931306575323245\ \(0\)\
\-\ biopsy\\:\\ 0\\.047370206900574384\ \(0\)\
\-\ effect\\:\\ 0\\.04727434770420695\ \(0\)\
\-\ week\\:\\ 0\\.045343990911378564\ \(0\)\
\-\ white\\:\\ 0\\.04428287832362528\ \(0\)\
\-\ showed\\:\\ 0\\.04377817606130776\ \(0\)\
\-\ her\\:\\ 0\\.04014705716382712\ \(0\)\
\-\ 6\\:\\ 0\\.03987687752148241\ \(0\)\
\-\ lymphoma\\:\\ 0\\.038159353662335714\ \(0\)\
\-\ presented\\:\\ 0\\.036396213047225144\ \(0\)\
\-\ enhancement\\:\\ 0\\.03578888697067244\ \(0\)\
\-\ lesions\\:\\ 0\\.03574313291162418\ \(0\)\
\-\ who\\:\\ 0\\.034812006392839094\ \(0\)\
\-\ consistent\\:\\ 0\\.03273903545048755\ \(0\)\
\-\ bilateral\\:\\ 0\\.03240340202053819\ \(0\)\
\-\ woman\\:\\ 0\\.03084223355451416\ \(0\)\
\-\ contrast\\:\\ 0\\.02988712010637352\ \(0\)\
\-\ no\\:\\ 0\\.026888879709493812\ \(0\)\
\-\ also\\:\\ 0\\.026322181151096115\ \(0\)\
\-\ mass\\:\\ 0\\.018569703233555696\ \(0\)\
\-\ history\\:\\ 0\\.018440852151673178\ \(0\)\
\-\ year\\:\\ 0\\.014939144832389293\ \(0\)\
\-\ old\\:\\ 0\\.013670853075972728\ \(0\)\
\-\ to\\:\\ 0\\.00667293919442166\ \(0\)\
\-\ a\\:\\ 0\\.006196871903415645\ \(0\)\
\-\ and\\:\\ 0\\.005625281429131827\ \(0\)\
\-\ with\\:\\ 0\\.0036563805028090542\ \(0\)\
\-\ \\.\\:\\ 0\\.0027734012576051776\ \(0\)\
\-\ of\\:\\ 0\\.0018203718874685692\ \(0\)\
